These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 24681666)
21. β-Catenin and NF-κB cooperate to regulate the uPA/uPAR system in cancer cells. Moreau M; Mourah S; Dosquet C Int J Cancer; 2011 Mar; 128(6):1280-92. PubMed ID: 20473943 [TBL] [Abstract][Full Text] [Related]
28. The urokinase receptor promotes cancer metastasis independently of urokinase-type plasminogen activator in mice. Jo M; Takimoto S; Montel V; Gonias SL Am J Pathol; 2009 Jul; 175(1):190-200. PubMed ID: 19497996 [TBL] [Abstract][Full Text] [Related]
29. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression. Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015 [TBL] [Abstract][Full Text] [Related]
30. Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro. Stahl A; Mueller BM Cancer Res; 1994 Jun; 54(11):3066-71. PubMed ID: 8187097 [TBL] [Abstract][Full Text] [Related]
31. Downregulation of uPA/uPAR inhibits intermittent hypoxia-induced epithelial-mesenchymal transition (EMT) in DAOY and D283 medulloblastoma cells. Gupta R; Chetty C; Bhoopathi P; Lakka S; Mohanam S; Rao JS; Dinh DE Int J Oncol; 2011 Mar; 38(3):733-44. PubMed ID: 21181094 [TBL] [Abstract][Full Text] [Related]
32. siRNA-mediated simultaneous downregulation of uPA and its receptor inhibits angiogenesis and invasiveness triggering apoptosis in breast cancer cells. Subramanian R; Gondi CS; Lakka SS; Jutla A; Rao JS Int J Oncol; 2006 Apr; 28(4):831-9. PubMed ID: 16525631 [TBL] [Abstract][Full Text] [Related]
33. Knockdown of cathepsin B and uPAR inhibits CD151 and α3β1 integrin-mediated cell adhesion and invasion in glioma. Rao Malla R; Gopinath S; Alapati K; Gorantla B; Gondi CS; Rao JS Mol Carcinog; 2013 Oct; 52(10):777-90. PubMed ID: 22495828 [TBL] [Abstract][Full Text] [Related]
34. Urokinase-type plasminogen activator receptor (uPAR) ligation induces a raft-localized integrin signaling switch that mediates the hypermotile phenotype of fibrotic fibroblasts. Grove LM; Southern BD; Jin TH; White KE; Paruchuri S; Harel E; Wei Y; Rahaman SO; Gladson CL; Ding Q; Craik CS; Chapman HA; Olman MA J Biol Chem; 2014 May; 289(18):12791-804. PubMed ID: 24644284 [TBL] [Abstract][Full Text] [Related]
35. uPA/uPAR system activation drives a glycolytic phenotype in melanoma cells. Laurenzana A; Chillà A; Luciani C; Peppicelli S; Biagioni A; Bianchini F; Tenedini E; Torre E; Mocali A; Calorini L; Margheri F; Fibbi G; Del Rosso M Int J Cancer; 2017 Sep; 141(6):1190-1200. PubMed ID: 28577299 [TBL] [Abstract][Full Text] [Related]
36. Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness. Bryan L; Paugh BS; Kapitonov D; Wilczynska KM; Alvarez SM; Singh SK; Milstien S; Spiegel S; Kordula T Mol Cancer Res; 2008 Sep; 6(9):1469-77. PubMed ID: 18819934 [TBL] [Abstract][Full Text] [Related]
38. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion. Hildenbrand R; Schaaf A Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473 [TBL] [Abstract][Full Text] [Related]
39. Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38alpha mitogen-activated protein kinase activity. Huang S; New L; Pan Z; Han J; Nemerow GR J Biol Chem; 2000 Apr; 275(16):12266-72. PubMed ID: 10766865 [TBL] [Abstract][Full Text] [Related]